v3.26.3
Note 11 - Segment Information - Reconciliation of Expense Categories (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
REVENUES $ 187,809     $ 34,791     $ 212,452 $ 231,666
Cost of goods sold 615,830     701,987     2,010,471 1,513,681
Research and development 4,256,779     2,577,786     11,993,032 8,340,593
General and administrative 1,989,349     1,423,632     5,798,844 3,953,429
Total Costs and Expenses 8,361,614     5,803,996     24,121,568 17,112,987
Loss from Operations (8,173,805)     (5,769,205)     (23,909,116) (16,881,321)
Interest income 528,798     380,729     1,172,944 862,621
Foreign currency exchange gain 306,120     95,296     25,096 1,254,790
Other expense (6,400)     (3,599)     (21,710) (13,399)
Total Other Income (Expense) 5,264,177     2,275,118     (4,139,284) 245,881
Net loss (2,909,628) $ (7,381,761) $ (17,757,011) (3,494,087) $ (7,795,322) $ (5,346,031) (28,048,400) (16,635,440)
Operating Segments [Member]                
REVENUES 187,809     34,791     212,452 231,666
Cost of goods sold 615,830     701,987     2,010,471 1,513,681
Sales expenses 811,930     652,484     2,232,046 1,967,280
Marketing expenses 687,726     448,107     2,087,175 1,338,004
Regulatory affairs and quality assurance expenses 1,175,225     777,474     3,014,853 2,448,428
General and administrative 1,989,349     1,423,632     5,798,844 3,953,429
Total Costs and Expenses 8,361,614     5,803,996     24,121,568 17,112,987
Loss from Operations (8,173,805)     (5,769,205)     (23,909,116) (16,881,321)
Interest income 528,798     380,729     1,172,944 862,621
Foreign currency exchange gain 306,120     95,296     25,096 1,254,790
Other expense 4,429,259     1,799,093     (5,337,324) (1,871,530)
Total Other Income (Expense) 5,264,177     2,275,118     (4,139,284) 245,881
Net loss (2,909,628)     (3,494,087)     (28,048,400) (16,635,440)
Operating Segments [Member] | Equipment Revenue [Member]                
REVENUES 168,970     8,461     186,287 29,272
Operating Segments [Member] | Consumable Revenue [Member]                
REVENUES 2,467     4,971     (32,715) 139,957
Operating Segments [Member] | Service [Member]                
REVENUES 16,372     21,359     58,880 62,437
Operating Segments [Member] | Clinical Research [Member]                
Research and development 854,921     562,065     3,060,795 1,699,353
Operating Segments [Member] | Product and Service, Other [Member]                
Research and development $ 2,226,633     $ 1,238,247     $ 5,917,384 $ 4,192,812